N30 Pharma In Deal With NitroMed

Boulder, Colorado-based N30 Pharma said Monday that it has inked a licensing deal with NitroMed, cover respiratory use of the firm's s-nitrosothiol drug candidate. Financial terms were not disclosed. N30 Pharma is a biopharmaceuticals firm focused on discovery, development, and commercialization of respiratory drugs, used for treating cystic fibrosis, asthma, and chronic obstructive pulmonary disease.